Skip to content

RxSight, Inc. RXST Net Investment in Lease

Net Investment in Lease at other companies

Schering-Plough logo
Schering-PloughSGP
Ocular Therapeutix logo
Ocular TherapeutixOCUL
Precision Optics Corporation logo
Precision Optics CorporationPOCI
Glaukos logo
GlaukosGKOS

Other financials

Income statement

See full
Revenue$30.9M-18.5%
Gross profit$23.5M-17.1%
Operating income-$17.8M-67.0%
Net income-$15.9M-93.9%
EPS (diluted)-$0.38-90.0%

Balance sheet

See full
Cash & equivalents$17.6M-37.2%
Total debt$10.8M-10.1%
Total equity$267.3M-4.3%
Total assets$304.0M-2.9%

Cash flow

See full
Operating cash flow-$10.9M-23.3%
CapEx$759.0K+32.0%
Free cash flow-$11.7M-23.8%

Valuation

See full
Market cap$232.23M-56.8%
Enterprise value$225.49M-55.7%
P/S1.8×-1.8×

Profitability

See full
Gross margin77%+5.1pp
Operating margin-43.4%+128pp
Net margin-36.6%-867pp
FCF margin-16.9%+4.9pp

Returns & leverage

See full
Return on equity-17.1%+12.6pp
Debt / equity0.0×
Current ratio10.2×-2.5×

Where this comes from

Reported directly by RxSight, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about RxSight, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RxSight, Inc.'s net investment in lease?
RxSight, Inc. (RXST) reported net investment in lease of $9.76M in Q1 2026.
How has RxSight, Inc.'s net investment in lease changed year-over-year?
RxSight, Inc.'s net investment in lease decreased by 10.6% year-over-year, from $10.92M to $9.76M.
What is the long-term trend for RxSight, Inc.'s net investment in lease?
Over 5 years (2020 to 2025), RxSight, Inc.'s net investment in lease has grown at a 13.4% compound annual growth rate (CAGR), from $5.32M to $9.96M.